These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8199714

  • 1. Vasopressin and a nonpeptide antidiuretic hormone receptor antagonist (OPC-31260).
    Burrell LM, Phillips PA, Stephenson JM, Risvanis J, Johnston CI.
    Blood Press; 1994 Mar; 3(1-2):137-41. PubMed ID: 8199714
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the rat.
    Burrell LM, Phillips PA, Stephenson J, Risvanis J, Hutchins AM, Johnston CI.
    J Endocrinol; 1993 Aug; 138(2):259-66. PubMed ID: 8228734
    [Abstract] [Full Text] [Related]

  • 3. Effects of an orally active vasopressin V1 receptor antagonist.
    Burrell LM, Phillips PA, Stephenson J, Risvanis J, Hutchins AM, Johnston CI.
    Clin Exp Pharmacol Physiol; 1993 May; 20(5):388-91. PubMed ID: 8391950
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist.
    Yamamura Y, Ogawa H, Yamashita H, Chihara T, Miyamoto H, Nakamura S, Onogawa T, Yamashita T, Hosokawa T, Mori T.
    Br J Pharmacol; 1992 Apr; 105(4):787-91. PubMed ID: 1387020
    [Abstract] [Full Text] [Related]

  • 5. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors.
    Manning M, Misicka A, Olma A, Klis WA, Bankowski K, Nawrocka E, Kruszynski M, Kolodziejczyk A, Cheng LL, Seto J.
    J Med Chem; 1987 Dec; 30(12):2245-52. PubMed ID: 2960812
    [Abstract] [Full Text] [Related]

  • 6. Vascular responses to vasopressin antagonists in man and rat.
    Burrell LM, Phillips PA, Rolls KA, Buxton BF, Johnston CI, Liu JJ.
    Clin Sci (Lond); 1994 Oct; 87(4):389-95. PubMed ID: 7834989
    [Abstract] [Full Text] [Related]

  • 7. OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats.
    Yamamura Y, Nakamura S, Itoh S, Hirano T, Onogawa T, Yamashita T, Yamada Y, Tsujimae K, Aoyama M, Kotosai K, Ogawa H, Yamashita H, Kondo K, Tominaga M, Tsujimoto G, Mori T.
    J Pharmacol Exp Ther; 1998 Dec; 287(3):860-7. PubMed ID: 9864265
    [Abstract] [Full Text] [Related]

  • 8. Human internal mammary artery responses to non-peptide vasopressin antagonists.
    Liu JJ, Phillips PA, Burrell LM, Buxton BB, Johnston CI.
    Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):121-4. PubMed ID: 8039263
    [Abstract] [Full Text] [Related]

  • 9. 7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoyl-amino)benzoyl ]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): a potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist.
    Kondo K, Ogawa H, Yamashita H, Miyamoto H, Tanaka M, Nakaya K, Kitano K, Yamamura Y, Nakamura S, Onogawa T, Mori T, Tominaga M.
    Bioorg Med Chem; 1999 Aug; 7(8):1743-54. PubMed ID: 10482466
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.
    Tahara A, Saito M, Sugimoto T, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):63-9. PubMed ID: 9459574
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Arg8]-vasopressin-induced increase in intracellular Ca2+ concentration in cultured rat hippocampal neurons.
    Mihara T, Tarumi T, Sugimoto Y, Chen Z, Kamei C.
    Brain Res Bull; 1999 Jul 15; 49(5):343-7. PubMed ID: 10452354
    [Abstract] [Full Text] [Related]

  • 13. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G, De Wied D.
    Brain Res; 1997 Jun 06; 759(1):18-23. PubMed ID: 9219858
    [Abstract] [Full Text] [Related]

  • 14. Antidiuretic effects of a nonpeptide vasopressin V(2)-receptor agonist, OPC-51803, administered orally to rats.
    Nakamura S, Hirano T, Tsujimae K, Aoyama M, Kondo K, Yamamura Y, Mori T, Tominaga M.
    J Pharmacol Exp Ther; 2000 Dec 06; 295(3):1005-11. PubMed ID: 11082435
    [Abstract] [Full Text] [Related]

  • 15. Organic osmolytes in rat renal inner medulla are modulated by vasopressin V1 and/or V2 antagonists.
    Nakanishi T, Yamauchi A, Nakahama H, Yamamura Y, Yamada Y, Orita Y, Fujiwara Y, Uyeda N, Takamitsu Y, Sugita M.
    Am J Physiol; 1994 Jul 06; 267(1 Pt 2):F146-52. PubMed ID: 8048555
    [Abstract] [Full Text] [Related]

  • 16. In vivo and in vitro characterisation of a nonpeptide vasopressin V(1A) and V(2) receptor antagonist (YM087) in the rat.
    Risvanis J, Naitoh M, Johnston CI, Burrell LM.
    Eur J Pharmacol; 1999 Sep 17; 381(1):23-30. PubMed ID: 10528130
    [Abstract] [Full Text] [Related]

  • 17. Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.
    Serradeil-Le Gal C, Lacour C, Valette G, Garcia G, Foulon L, Galindo G, Bankir L, Pouzet B, Guillon G, Barberis C, Chicot D, Jard S, Vilain P, Garcia C, Marty E, Raufaste D, Brossard G, Nisato D, Maffrand JP, Le Fur G.
    J Clin Invest; 1996 Dec 15; 98(12):2729-38. PubMed ID: 8981918
    [Abstract] [Full Text] [Related]

  • 18. Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands.
    Phillips PA, Abrahams JM, Kelly JM, Mooser V, Trinder D, Johnston CI.
    Endocrinology; 1990 Mar 15; 126(3):1478-84. PubMed ID: 2307115
    [Abstract] [Full Text] [Related]

  • 19. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
    Furukawa Y, Takayama S, Ren LM, Sawaki S, Inoue Y, Chiba S.
    J Pharmacol Exp Ther; 1992 Nov 15; 263(2):627-31. PubMed ID: 1331408
    [Abstract] [Full Text] [Related]

  • 20. Vasopressin and oxytocin receptors on plasma membranes from rat mammary gland. Demonstration of vasopressin receptors by stimulation of inositol phosphate formation, and oxytocin receptors by binding of a specific 125I-labeled oxytocin antagonist, d(CH2)5(1)[Tyr(Me)2, Thr4,Tyr-NH2(9)]OVT.
    Soloff MS, Fernström MA, Fernström MJ.
    Biochem Cell Biol; 1989 Nov 15; 67(2-3):152-62. PubMed ID: 2546575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.